The complexity of p53-mediated metabolic regulation in tumor suppression
Although the classic activities of p53 including induction of cell-cycle arrest, senescence,
and apoptosis are well accepted as critical barriers to cancer development, accumulating …
and apoptosis are well accepted as critical barriers to cancer development, accumulating …
Mutant p53 gain-of-function: role in cancer development, progression, and therapeutic approaches
E Alvarado-Ortiz, KG de la Cruz-López… - Frontiers in cell and …, 2021 - frontiersin.org
Frequent p53 mutations (mutp53) not only abolish tumor suppressor capacities but confer
various gain-of-function (GOF) activities that impacts molecules and pathways now regarded …
various gain-of-function (GOF) activities that impacts molecules and pathways now regarded …
Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK/mTOR/ERK signaling
Mitochondrial dynamics are balanced fission and fusion events that regulate mitochondrial
morphology, and alteration in these events results in mitochondrial dysfunction and …
morphology, and alteration in these events results in mitochondrial dysfunction and …
The functions and roles of sestrins in regulating human diseases
Y Chen, T Huang, Z Yu, Q Yu, Y Wang, J Hu… - Cellular & Molecular …, 2022 - Springer
Sestrins (Sesns), highly conserved stress-inducible metabolic proteins, are known to protect
organisms against various noxious stimuli including DNA damage, oxidative stress …
organisms against various noxious stimuli including DNA damage, oxidative stress …
[HTML][HTML] Melanocortin 1 receptor attenuates early brain injury following subarachnoid hemorrhage by controlling mitochondrial metabolism via AMPK/SIRT1/PGC-1α …
Mitochondria-mediated oxidative stress and apoptosis contribute greatly to early brain injury
(EBI) following subarachnoid hemorrhage (SAH). This study hypothesized that activation of …
(EBI) following subarachnoid hemorrhage (SAH). This study hypothesized that activation of …
Mutant p53-associated molecular mechanisms of ROS regulation in cancer cells
M Cordani, G Butera, R Pacchiana, F Masetto… - Biomolecules, 2020 - mdpi.com
The TP53 tumor suppressor gene is the most frequently altered gene in tumors and an
increasing number of studies highlight that mutant p53 proteins can acquire oncogenic …
increasing number of studies highlight that mutant p53 proteins can acquire oncogenic …
Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes
LN Redman-Rivera, TM Shaver, H **… - Nature …, 2021 - nature.com
Abstract p53 is mutated in over half of human cancers. In addition to losing wild-type (WT)
tumor-suppressive function, mutant p53 proteins are proposed to acquire gain-of-function …
tumor-suppressive function, mutant p53 proteins are proposed to acquire gain-of-function …
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders
G Butera, N Mullappilly, F Masetto, M Palmieri… - International Journal of …, 2019 - mdpi.com
Several studies indicate that the cytosolic enzyme glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) has pleiotropic functions independent of its canonical role in …
dehydrogenase (GAPDH) has pleiotropic functions independent of its canonical role in …
Targeting mutant p53 stabilization for cancer therapy
J Wang, W Liu, L Zhang, J Zhang - Frontiers in Pharmacology, 2023 - frontiersin.org
Over 50% cancer bears TP53 mutation, the highly stabilized mutant p53 protein drives the
tumorigenesis and progression. Mutation of p53 not only cause loss-of-function and …
tumorigenesis and progression. Mutation of p53 not only cause loss-of-function and …
UCP2 as a cancer target through energy metabolism and oxidative stress control
A Luby, MC Alves-Guerra - International journal of molecular sciences, 2022 - mdpi.com
Despite numerous therapies, cancer remains one of the leading causes of death worldwide
due to the lack of markers for early detection and response to treatment in many patients …
due to the lack of markers for early detection and response to treatment in many patients …